Publication | Open Access
Predictive factors for poor progression-free survival in patients with non-small-cell lung cancer treated with nivolumab
45
Citations
0
References
2017
Year
Non-small-cell Lung CancerMedicinePredictive FactorsCancer ManagementBronchial NeoplasmImmune Checkpoint InhibitorCancer TreatmentPoor Progression-free SurvivalOncologyRadiation OncologyLung Cancer
No additional data available for this publication yet. Check back later!